Kushev D N, Spassovska N C, Taxirov S I, Grancharov K C
Institute of Molecular Biology, Bulgarian Academy of Sciences, Sofia, Bulgaria.
Z Naturforsch C J Biosci. 1997 Jan-Feb;52(1-2):49-54.
New platinum (II) complexes of cyclohexanecarboxylic acid hydrazide (chcah) were synthesized and characterized by elemental analysis, IR, and 1H NMR spectra. Their inhibitory effects on cell growth and macromolecular synthesis of Friend leukemia cells in culture as well as the in vivo antitumor activity towards L1210 leukemia in mice were compared with those of complexes containing differently substituted aromatic acid hydrazides. Some of the complexes exhibited antineoplastic activity. No correlation between the in vivo cytotoxicity and the in vivo antitumor activity was found. However, there was a relationship between the in vitro macromolecular synthesis inhibition profile and the in vivo antineoplastic effect, similar to that of cisplatin. On the other hand, only agents containing one amine ligand were active in vivo. The substitution of the aromatic ring by a cycloalkane residue increased significantly the antitumor effect, with [Pt(NH3)(chcah)Cl2] being the most active compound in this study.
合成了环己烷羧酸酰肼(chcah)的新型铂(II)配合物,并通过元素分析、红外光谱和1H核磁共振光谱对其进行了表征。将它们对培养的Friend白血病细胞的细胞生长和大分子合成的抑制作用以及对小鼠L1210白血病的体内抗肿瘤活性与含有不同取代芳香酸酰肼的配合物进行了比较。一些配合物表现出抗肿瘤活性。未发现体内细胞毒性与体内抗肿瘤活性之间存在相关性。然而,体外大分子合成抑制谱与体内抗肿瘤作用之间存在关系,类似于顺铂。另一方面,只有含有一个胺配体的试剂在体内具有活性。用环烷烃残基取代芳环显著增强了抗肿瘤作用,[Pt(NH3)(chcah)Cl2]是本研究中活性最高的化合物。